Premature DNA copying may damage resting cells as they resume growth and favour altered clones
Coinciding spermidine exposure and feeding may push normal cells leaving rest into DNA copying before preparation is complete, favouring altered clones. The explanation is rejected if the scheduling benefit persists after replication preparation is equalised.
Stage of verification
- Hypothesis published2026-10-06
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Biological function
The biological function description is being prepared
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Rhythm or programme
DNA replication licensing
Preparation of replication initiation sites before DNA synthesis, involving loading of the MCM2-7 helicase complex
Where this hypothesis actsNormal cells entering their first DNA replication after leaving quiescence
Hypotheses on this target 1
Inhibition
Activation
Function preservation
Feedback restoration
Rhythm restoration1
Direct measurement
What is proposed
Rhythm restoration
Allow replication preparation to finish before the first S phase
With whatChange of environment or regimen
HowSeparate the autophagic pulse from strong nutrient signaling, or briefly extend G1 through reversible action on cyclin-dependent kinases while preserving autophagy
Possible result
Possible reduction in DNA damage in normal cells and in the subsequent advantage of the altered clone
From the recordРазведение аутофагического импульса и сильного пищевого сигнала позволяет завершить подготовку репликации.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
A treatment meant to reproduce the benefits of fasting could also give altered cells an advantage over their normal neighbours. The unexpected move is to locate that danger in normal cells restarting growth before they are ready to copy their genetic material, rather than primarily in immune attack or competition driven by substances released by neighbouring cells. This is a proposal generated by the pipeline, not a measured result.
- The proposal begins with a spermidine-based treatment coinciding with renewed feeding and strengthening the signal for cells to grow.
- Normal cells switch from a resting state to repeated growth and division, with less time available before their first DNA copying begins.
- Copying begins before enough minichromosome maintenance proteins 2–7, or MCM2–7, a protein complex needed to prepare copying start sites and later unwind DNA, have been loaded onto the genetic material.
- Insufficiently prepared copying is proposed to damage DNA and stop normal cells during their first return to division.
- An altered clone already dividing avoids this restart hazard and gains an advantage as normal competitors stop.
- Separating the recycling stimulus from renewed feeding is proposed to restore preparation time and preserve normal competitors while retaining cellular recycling.
A workshop reopening after a shutdown needs time to prepare its equipment before production starts. Bringing the deadline forward could cause breakdowns in the reopening workshop while a neighbouring workshop already operating keeps going.
Where the picture breaks: Cells do not follow a centrally assigned production deadline, and this picture does not establish that the treatment shortens preparation or that altered cells escape damage. Both are claims the proposed test must examine.
- Master questionstep 01 of 04
Useful processes already carried out by the body might be reproduced by substances, combinations of substances or other interventions to extend life.
Rests on: The supplied goal explicitly calls for new hypotheses about reproducing beneficial bodily processes and explaining how they might extend life.
Stated in the chain - Goal pillarstep 02 of 04
A treatment that reproduces a beneficial bodily process needs a durable margin before its effects turn harmful.
Rests on: The goal seeks longer life, which motivates considering whether an intervention's benefits can persist without being overtaken by harm.
AssumptionThe pillar assumes that a durable margin between benefit and harm is a useful organizing requirement; the master question does not specify that requirement or define its measurement.
- Gap questionstep 03 of 04
Changing the relative timing of feeding, tissue repair and removal of cells by the immune system might preserve autophagy, the cell's breakdown and recycling of its own components, while preventing altered cell families from gaining a competitive advantage at the same total treatment exposure. The proposed treatment is a polyamine mimetic, an intervention intended to reproduce effects associated with a class of compounds involved in cell function and growth.
Rests on: The preceding pillar calls for a margin between benefit and harm, but supplies no particular treatment, competing cellular effects or timing mechanism.
LeapThe narrowing to a polyamine treatment, cellular recycling, competitive expansion of altered cells and the relative timing of three processes is not supplied by the preceding stage. The screened sources do not establish that this particular benefit–harm pairing can be separated at equal total exposure.
- Hypothesisstep 04 of 04
Normal cells returning from rest are proposed to begin copying deoxyribonucleic acid, or DNA, their genetic material, before enough copying machinery has been put in place when a spermidine-based fasting mimic coincides with renewed feeding. Spermidine is a polyamine compound. The resulting damage would stop normal cells while an altered clone, a family descended from an altered cell, already undergoing repeated divisions avoids this particular restart hazard. Separating the signals is proposed to preserve normal competitors by allowing preparation to finish.S1S4
Rests on: The preceding stage supplies the timing problem. The Journal of Cell Biology study from 2019 reports greater difficulty copying DNA during the first copying phase after rest and proposes insufficient preparation of copying start sites as an explanation; it does not test spermidine, feeding schedules or competition between normal and altered cells. Advances in Experimental Medicine and Biology in 2017 links an abbreviated preparation period and early copying to DNA damage, but does not establish the proposed treatment-to-competition sequence.
Supported by literature
What is carried, and what is not. Screened literature supports two ingredients of the explanation: vulnerability during the first DNA copying after rest, and a connection between shortened preparation and copying damage. S1 and S4 do not establish the sequence from spermidine and feeding through selective damage to a competitive advantage for altered cells, and no supplied source establishes that sequence end to end.S1S4
Where the reasoning is carried by something unstated · 2
- Goal pillar. The pillar assumes that a durable margin between benefit and harm is a useful organizing requirement; the master question does not specify that requirement or define its measurement.
- Gap question. The narrowing to a polyamine treatment, cellular recycling, competitive expansion of altered cells and the relative timing of three processes is not supplied by the preceding stage. The screened sources do not establish that this particular benefit–harm pairing can be separated at equal total exposure. Establish the missing link before relying on this step.
How a result here could mislead · 3
- Extending the preparation period could reduce the altered clone's apparent advantage simply by slowing division, without correcting the proposed copying defect. What closes it: The specification requires comparison of completed divisions across the full cycle. Restoration of DNA-bound MCM2–7, reduction of subsequent damage and preservation of cellular recycling must accompany the competition result; fewer divisions alone do not establish rescue.
- A difference between resting normal cells and continuously dividing altered cells could be credited to altered-cell identity even if it is caused by their different starting states. What closes it: Starting state must be compared separately within normal and altered cells, including return from rest and continuous division. Damage and subsequent growth must be tracked in each group; the supplied specification calls for a starting-state comparison but does not fully specify this crossed comparison.
- A benefit from separating treatment and feeding could be credited to DNA preparation even if it comes from immune removal or NOTUM, a secreted enzyme proposed by a rival explanation to suppress recovery of neighbouring cells. What closes it: The predicted preparation defect must persist with NOTUM disabled and immune cells absent, as the hypothesis specifies. The timing advantage must then disappear when preparation is equalized; persistence under those conditions would reject the proposed explanation even if the schedule remained beneficial.
What would make this wrong. The hypothesis explicitly rejects its explanation if separating treatment and feeding still gives a competitive benefit after preparation for DNA copying has been equalized. That observation would mean the proposed preparation defect does not account for the schedule's advantage.
What it would change. If the mechanism held, developing fasting-like treatments for longer life would require considering whether normal cells are ready to copy their DNA when feeding resumes. A useful schedule would be defined partly by that readiness, rather than by total exposure alone. An initial result in organoids, laboratory-grown three-dimensional tissue models, would still not establish the mechanism in aged intestinal stem cells, the cells that replenish the intestinal lining, or show that any schedule extends life. The supplied material also does not define SPV_9, so its proposed stabilization cannot be translated into an established biological outcome.
Sources read · 7
Intrinsic checkpoint deficiency during cell cycle re-entry from quiescence. · The Journal of cell biology · 2019
“increased endogenous replication stress in the first S phase compared with proliferating cells. We propose that the underlicensed S phase after the first G1 has higher endogenous replication stress because fewer dormant origins are available.”
Does not settle: Источник связывает первую фазу синтеза ДНК после выхода из покоя с недостаточным лицензированием точек начала репликации и повышенным репликационным стрессом. Он не исследует спермидиновый миметик, аутофагический импульс, разведение его по времени с возобновлением питания, конкурентный отбор изменённых клонов, сохранение нормальных клеток, стабилизацию SPV_9 или роль иммунного удаления. Частота естественного недостаточного лицензирования первого клеточного цикла in vivo также остаётся неизвестной.
SAF-A promotes origin licensing and replication fork progression to ensure robust DNA replication. · Journal of cell science · 2022
“We report that cells depleted of SAF-A show reduced origin licensing in G1 phase and, consequently, reduced origin activation frequency in S phase.”
Does not settle: Остаются открытыми последствия выхода нормальных клеток из покоя, роль спермидинового миметика и возобновления питания, соотношение сроков загрузки MCM2-7 и начала S-фазы, преимущество изменённых клонов и защитный эффект разнесения сигналов во времени.
Targeting minichromosome maintenance proteins in cancer stem cells: mechanisms and therapeutic opportunities. · Biochemical pharmacology · 2025
“Importantly, in G0 and early G1, MCM2-7 are either not loaded or not yet activated; helicase activity arises only after CMG assembly at the G1/S transition.”
Does not settle: The abstract does not establish that growth stimulation causes premature DNA replication before adequate MCM2-7 loading, nor that this damages normal cells exiting quiescence, selects for altered cycling clones, or is prevented by separating a spermidine-mimetic/autophagic pulse from nutrient refeeding.
The Temporal Regulation of S Phase Proteins During G1. · Advances in experimental medicine and biology · 2017
“High CDK activity shortens G 1 , i.e. , causes premature entry into S phase. Early entry into S phase, in turn, can result in increased endogenous DNA damage, presumably from inadequate G 1 preparation or an uncoordinated G 1 /S transition.”
Does not settle: Источник связывает преждевременный вход в фазу S с повреждением ДНК, но не устанавливает роль миметика спермидина, возобновления питания, недостаточной загрузки комплекса MCM2-7, избирательной остановки нормальных клеток, преимущества изменённого клона или защитного эффекта разнесения аутофагического и пищевого сигналов.
CUL4B promotes replication licensing by up-regulating the CDK2-CDC6 cascade. · The Journal of cell biology · 2013
“Thus, aside being required for cell cycle reentry from quiescence, CDK2 also contributes to pre-replication complex assembly in G1 phase of cycling cells.”
Does not settle: Остаются открытыми преждевременное начало репликации при возобновлении питания, недостаточная загрузка MCM2-7, повреждение и остановка нормальных клеток, преимущество изменённых клонов, действие спермидинового миметика и польза разнесения аутофагического и пищевого сигналов для стабилизации SPV_9.
DNA replication licensing in peripheral B-cell lymphoma. · The Journal of pathology · 2005
“Given that tight Mcm2 downregulation defines the quiescent state (G0) and that both high- and low-growth fraction lymphomas express Mcm2, the data demonstrate that neoplastic lymphocytes of SLL/CLL and MCL reside in an "in-cycle" G1 state and not in G0 as previously thought.”
Does not settle: Источник не исследует нормальные клетки при выходе из покоя, возобновление питания, спермидиновый миметик, сроки загрузки комплекса MCM2-7, преждевременное начало репликации, повреждение ДНК, остановку клеточного цикла, отбор изменённых клонов или разведение аутофагического и пищевого сигналов.
Repression of DNA replication licensing in quiescence is independent of geminin and may define the cell cycle state of progenitor cells. · Experimental cell research · 2005
“We show that in the quiescent state (G0) loss of proliferative capacity is achieved in part through down-regulation of the replication licensing factors Cdc6 and Mcm2-7.”
Does not settle: The source does not establish that growth stimulation triggers DNA synthesis before MCM2-7 loading is complete, causes replication damage or arrest, selects altered cycling clones, involves a spermidine mimetic or autophagy, or that separating autophagic and nutritional signals prevents these outcomes.
The gap this hypothesis explains
Can timing a polyamine-like treatment preserve cellular recycling benefits without favoring particular cell families at equal total exposure?
Original wording · exactly as the pipeline generated it
Можно ли разделить аутофагическую пользу и клональный отбор при действии полиаминового миметика, изменяя взаимное время питания, регенерации и иммунного удаления при одинаковом суммарном воздействии?
What this question is asking
The question asks whether changing a treatment’s timing can separate a helpful effect on cellular recycling from an effect that favors some cell families over others. The treatment is a polyamine mimetic, a substance intended to imitate effects of compounds called polyamines. The proposed comparison keeps total treatment exposure equal while changing when treatment occurs relative to feeding, tissue rebuilding, and cell removal by the immune system. The question assumes that this treatment produces both a cellular recycling benefit and selection among cell families, but the supplied material does not establish either effect or identify the organism, treatment, or measurements.
- Polyamines
- A class of compounds found in cells. The question names this class as the reference for a treatment but specifies no individual compound or particular effect to be imitated.
- Polyamine mimetic
- A substance intended to imitate some effects of polyamines. The label describes an intended resemblance, not proof that it reproduces every effect of those compounds.
- Autophagy
- Processes through which cells break down and recycle their own material. An autophagic benefit means a beneficial consequence attributed to those processes; increased recycling alone does not define the benefit, and the supplied material gives no measure of it.
- Clone or cell family
- A group of cells descended from one starting cell. The question concerns whether treatment favors some such groups over others, without identifying which groups.
- Clonal selection
- Preferential survival or expansion of particular cell families compared with others. The term describes a change in the cell population and does not by itself establish whether that change is helpful or harmful.
- Regeneration
- Rebuilding or replacing tissue. The question treats the timing of this process as potentially relevant to the treatment’s effects.
- Immune clearance
- Removal of cells by the immune system, the body’s system for recognizing and responding to threats. The question does not specify which cells are removed or how the timing of removal is determined.
- Cumulative exposure
- The total exposure to treatment over the period being compared. Keeping this equal is intended to distinguish timing effects from differences in overall exposure, but the question does not define how that total is calculated.
- Physiological processes
- Processes through which living bodies function. The broader request concerns imitating such processes to extend life, but it supplies no evidence that this particular treatment would do so.
A polyamine mimetic produces an autophagic benefit and clonal selection that might be separated by changing timing relative to feeding, regeneration, and immune clearance at equal cumulative exposure.
The assumption concerns a treatment that imitates polyamines, cellular machinery that breaks down and recycles material, and groups of cells descended from individual starting cells. It assumes the treatment improves recycling while favoring some of those groups, creating two effects whose dependence on timing can be compared. Establishing both effects would give the proposed separation a concrete meaning.
No screened sources were supplied. There is therefore no read evidence establishing either treatment effect, their relationship, or the role of timing; this does not show that the assumption is false.
The same question asked without the part nothing read establishes:
- At equal total exposure, does changing a polyamine-like treatment’s timing relative to feeding, tissue rebuilding, and immune cell removal change cellular recycling benefits and the relative growth or survival of cell families?
- Does a polyamine-like treatment produce both beneficial cellular recycling and preferential growth or survival of particular cell families?
- Timing separates the effects At equal total exposure, one schedule would preserve the recycling benefit while reducing or avoiding preferential survival or expansion of particular cell families. Within the question’s framing, the timing of exposure would therefore determine whether these effects occur together; that result alone would not establish longer life.
- The effects remain linked Schedules that preserve the recycling benefit would also retain selection among cell families. Changing timing would then fail to provide the proposed separation within the conditions compared, and the recycling result would still need to be understood alongside the population change.
- The assumed pair of effects is absent If the treatment does not produce a recycling benefit or does not favor particular cell families, there would be no demonstrated pair of effects to separate. A difference between schedules would then answer a narrower question about whichever effect actually occurs.
The broader context is whether imitating physiological processes could help extend life. Under the question’s proposed mechanism, treatment would improve recycling within cells while also changing which cell families survive or expand. If timing separated these effects, the recycling benefit would not necessarily require the same change in the cell population. If it did not, treating improved recycling as sufficient evidence of an overall benefit could overlook changes in that population; the supplied material does not establish whether those changes would be harmful or affect lifespan.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Патологический отбор при совпадении спермидинового миметика с возобновлением питания может возникать из-за слишком раннего начала репликации ДНК в нормальных клетках, выходящих из покоя. Предполагается, что усиление роста сокращает время между выходом из покоя и фазой синтеза ДНК относительно времени загрузки комплекса репликативной хеликазы MCM2-7. Нормальные клетки входят в первую репликацию с недостаточно подготовленными точками начала, получают повреждения и останавливаются; уже циклирующий изменённый клон избегает именно этого переходного риска. Разведение аутофагического импульса и сильного пищевого сигнала позволяет завершить подготовку репликации. Оно сохраняет нормальных конкурентов и стабилизирует SPV_9. Здесь полезное окно задаётся готовностью хромосом к удвоению; расписание иммунного удаления вторично.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
Вредное совпадение фаз даст уменьшение количества связанного с хроматином MCM2-7 перед первой S-фазой, затем повреждения ДНК преимущественно в нормальных клетках, вышедших из покоя. Эффект сохранится при выключенном Notum и отсутствии иммунных клеток. Краткое продление подготовительной фазы G1 обратимым воздействием на циклинзависимые киназы должно восстановить загрузку MCM2-7 и уменьшить последующее преимущество изменённого клона при сохранении аутофагии. Для подтверждения требуется сопоставить завершённое число делений за весь цикл: простое подавление пролиферации недостаточно. Если преимущество расписания сохраняется после выравнивания подготовки репликации, это объяснение отвергается.
Would tell it apart from at least one rival. The prediction specifies observable changes in replication licensing, DNA damage and clonal advantage, conditions under which the effect persists, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Доступны измерение связанного с хроматином MCM2-7, флуоресцентное отслеживание клеточного цикла и анализ отдельных репликационных волокон. Первую проверку можно выполнить на изогенных органоидах, отдельно сравнивая выходящие из покоя и непрерывно циклирующие клетки. Перенос механизма на старые кишечные стволовые клетки требует прямого подтверждения.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
Вредное совпадение фаз даст уменьшение количества связанного с хроматином MCM2-7 перед первой S-фазой, затем повреждения ДНК преимущественно в нормальных клетках, вышедших из покоя. Эффект сохранится при выключенном Notum и отсутствии иммунных клеток. Краткое продление подготовительной фазы G1 обратимым воздействием на циклинзависимые киназы должно восстановить загрузку MCM2-7 и уменьшить последующее преимущество изменённого клона при сохранении аутофагии. Для подтверждения требуется сопоставить завершённое число делений за весь цикл: простое подавление пролиферации недостаточно. Если преимущество расписания сохраняется после выравнивания подготовки репликации, это объяснение отвергается.
- What would separate them
Immune killing of normal regenerating cells may favor precancerous clone growth predicts: В старых мышах с мечеными нормальными и Apc-изменёнными кишечными клетками совпадение спермидинового импульса, питания и иммунного пика сначала увеличит иммунные контакты и гибель нормальных клеток, затем увеличит абсолютную численность изменённого клона. Краткая блокада NKG2D только в этом окне либо удаление соответствующих лигандов только у нормальных клеток уменьшит поздний абсолютный рост клона при сохранении аутофагического потока. Перенос блокады на другое окно такого эффекта не даст. Отсутствие преимущественной иммунной гибели нормальных клеток опровергнет центральное звено, даже если изменение расписания окажется полезным.
- Rival 02 of 03What would separate them
Altered cells may suppress normal repair through an enzyme above a local abundance threshold predicts: При одинаковом расписании спермидина и одинаковой общей плотности клеток знак изменения доли изменённого клона будет зависеть от его исходной локальной доли. Перестановка фаз питания и удаления даст разные результаты по разные стороны измеренного порога. Генетическое выключение Notum в изменённых клетках устранит этот порог и соответствующее взаимодействие между исходной долей и расписанием, сохранив аутофагический ответ нормальных клеток. Если преимущество одинаково при разных долях и сохраняется после выключения Notum, предложенный механизм отвергается.
- Rival 03 of 03What would separate them
Different protein lifetimes may separate spermidine-driven cell recycling from clonal growth predicts: После спермидинового импульса обнаружится интервал, в котором аутофагический поток остаётся повышенным, а дополнительная активность MYC уже исчезла. Возобновление питания в этом интервале сохранит функциональную пользу при меньшем абсолютном росте изменённых клеток даже в культуре без иммунных клеток и при выключенном Notum. Экспериментальное продление времени жизни MYC закроет интервал, а обратимое удаление TFEB перед формированием лизосомной программы устранит сохраняющуюся аутофагическую пользу. Если белковые ответы затухают совместно либо изменение времени жизни MYC не меняет разделимость, гипотеза отвергается.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.